Claudia Styslinger | Investor Relations |
Gerri Henwood | President & Chief Executive Officer |
Ryan Lake | Chief Financial Officer |
John Harlow | Executive Vice President, Commercial |
David Amsellem | Piper Jaffray |
Leland Gershell | Oppenheimer & Co. |
Esther Hong | Janney |
Scott Henry | Roth Capital |
Patrick Trucchio | Berenberg Capital Market |
Good morning, and welcome to the Recro Pharma Fourth Quarter and Year-End 2018 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference is being recorded at the company's request. I would now like to turn the call over to Claudia Styslinger, Investor Relations.